Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Taxation topic
No spam. Unsubscribe anytime.
Senate Health Care panel refers pharmacy corporate-activity tax exemption bill to finance committee
Summary
The Senate Committee on Health Care voted Jan. 30 to move Senate Bill 379 without recommendation to the Senate president, requesting re-referral to the Senate Committee on Finance and Revenue. The bill would extend an exemption affecting receipts from prescription drug sales by certain pharmacies under Oregon’s corporate activity tax.
The Senate Committee on Health Care on Jan. 30 voted to move Senate Bill 379 without recommendation back to the Senate president and requested re-referral to the Senate Committee on Finance and Revenue.
Chair Patterson opened a work session on SB 379 and Vice Chair Hayden moved the motion “Senate Bill 379 without recommendation back to the Senate President requesting re referral to the Senate Committee on Finance and Revenue.” The clerk conducted a roll call and the motion passed.
The bill would extend an exemption from the corporate activity tax for receipts from sale of prescription drugs by certain pharmacies. Vice Chair Hayden described the change as intended to “keep the cost down” for pharmaceuticals and noted that taxation is ultimately a matter for the finance committee, not Health Care.
The committee’s action was procedural: the panel did not issue a committee recommendation on the merits and instead referred the measure to the Senate committee with jurisdiction over tax policy. No amendments or further committee actions on the substance were recorded during the work session.
What happened next: the committee closed its work session on SB 379 and proceeded to the public hearing portion of the agenda. The referral will allow the Senate Committee on Finance and Revenue to consider the tax implications of the exemption.
Votes at a glance: The motion to move SB 379 without recommendation was adopted; the clerk recorded “Aye” responses during roll call and the chair declared the motion passed.
